Gapping up
In reaction to strong earnings/guidance: NFLX +11.5%, ANFI +7.6%, ONDK +5.3%, EBAY +4%, C +2.5%, INTC +2.4%, KEY +2.3%, PM +2%, CPSS +1.3%, UMPQ +1.1%, KMI +1%, BBT +0.9%, DPZ +0.8%
Select financial related names showing strength: SAN +1.9%, ING +1.6%, DB +1%
Select metals/mining stocks trading higher: BHP +2.1%, AKS +2%, RIO +0.7% (reports Q2 production of iron ore rose 9% YoY), CAS +0.7%.
Select auto related names showing strength after good data out of EU: TTM +2.3%, FCAU +3%, TM +2.1%, ALV +1.6%
Other news: STV +16.6% (provides updates on its asset restructuring with Shanghai Tongda Venture Capital; Tongda has received an approval in principle from the Ministry of Commerce in China), NVGN +7.7% (confirms receipt of Orphan Drug Designation from the FDA for its Anisina treatment for neuroblastoma ), FTNT +4.4% (still checking), GLW +2.2% (announced $2 bln share repurchase program), RDUS +2.1% (reports positive preclinical data for its investigational drug RAD1901 in combination with CDK and mTOR inhibitors), MGA +2.1% (confirms it will acquire the Getrag Group of Companies for EUR 1.75 bln), STM +2% (in sympathy with INTC), PVA +1.9% (sells its East Texas assets to an undisclosed buyer for $75 million), SDRL +1.8% (still checking), BLPH +1.7% (entered into an amendment to the transition services agreement with Ikaria to advance the termination date of the Services Agreement from February 8, 2016 to September 30, 2015), NBG +1.7% (Greek Parliament passes bailout deal), GPRO +1.4% (still checking), MU +1.1% (in sympathy with INTC), MDXG +0.9% (scientific study demonstrates that MiMedx allografts stimulate cellular proliferation and migration in a variety of adult stem cells), KMI +0.9% (to purchase 100% of Shell's Equity Interest in the Elba LNG Liquefaction JV; KMI's expected incremental investment resulting from this transaction is ~$630 mln; co also reported earnings)
Analyst comments: ORAN +2.6% (upgraded to Buy at Berenberg), STO +2.1% (upgraded to Buy from Neutral at Citigroup), AVGO +1.4% (initiated with an Outperform at BMO Capital ), WBA +1.1% (upgraded to Outperform from Neutral at Credit Suisse), GOOGL +1% (upgraded to Outperform at BMO Capital Mkts
)
In reaction to strong earnings/guidance: NFLX +11.5%, ANFI +7.6%, ONDK +5.3%, EBAY +4%, C +2.5%, INTC +2.4%, KEY +2.3%, PM +2%, CPSS +1.3%, UMPQ +1.1%, KMI +1%, BBT +0.9%, DPZ +0.8%
Select financial related names showing strength: SAN +1.9%, ING +1.6%, DB +1%
Select metals/mining stocks trading higher: BHP +2.1%, AKS +2%, RIO +0.7% (reports Q2 production of iron ore rose 9% YoY), CAS +0.7%.
Select auto related names showing strength after good data out of EU: TTM +2.3%, FCAU +3%, TM +2.1%, ALV +1.6%
Other news: STV +16.6% (provides updates on its asset restructuring with Shanghai Tongda Venture Capital; Tongda has received an approval in principle from the Ministry of Commerce in China), NVGN +7.7% (confirms receipt of Orphan Drug Designation from the FDA for its Anisina treatment for neuroblastoma ), FTNT +4.4% (still checking), GLW +2.2% (announced $2 bln share repurchase program), RDUS +2.1% (reports positive preclinical data for its investigational drug RAD1901 in combination with CDK and mTOR inhibitors), MGA +2.1% (confirms it will acquire the Getrag Group of Companies for EUR 1.75 bln), STM +2% (in sympathy with INTC), PVA +1.9% (sells its East Texas assets to an undisclosed buyer for $75 million), SDRL +1.8% (still checking), BLPH +1.7% (entered into an amendment to the transition services agreement with Ikaria to advance the termination date of the Services Agreement from February 8, 2016 to September 30, 2015), NBG +1.7% (Greek Parliament passes bailout deal), GPRO +1.4% (still checking), MU +1.1% (in sympathy with INTC), MDXG +0.9% (scientific study demonstrates that MiMedx allografts stimulate cellular proliferation and migration in a variety of adult stem cells), KMI +0.9% (to purchase 100% of Shell's Equity Interest in the Elba LNG Liquefaction JV; KMI's expected incremental investment resulting from this transaction is ~$630 mln; co also reported earnings)
Analyst comments: ORAN +2.6% (upgraded to Buy at Berenberg), STO +2.1% (upgraded to Buy from Neutral at Citigroup), AVGO +1.4% (initiated with an Outperform at BMO Capital ), WBA +1.1% (upgraded to Outperform from Neutral at Credit Suisse), GOOGL +1% (upgraded to Outperform at BMO Capital Mkts
)